1. The dual effect of morphine on tumor development

   • H. Tuerxun
   • J. Cui

   Review Article Open access 23 November 2018 Pages: 695 - 701

   

2. Programmed cell death protein-1 (PD-1)/programmed death-ligand-1 (PD-L1) axis in hepatocellular carcinoma: prognostic and therapeutic perspectives

   • T. Mocan
   • Z. Sparchez
   • D. C. Leucuta

   Review Article 01 November 2018 Pages: 702 - 712

   

3. Cancer immunotherapy of patients with HIV infection

   • M. Gonzalez-Cao
   • J. Martinez-Picado
   • A. Meyerhans

   Review Article 17 November 2018 Pages: 713 - 720

4. Combination of DC/CIK adoptive T cell immunotherapy with chemotherapy in advanced non-small-cell lung cancer (NSCLC) patients: a prospective patients’ preference-based study (PPPS)

   • Y. Zhao
   • G. Qiao
   • H. K. Lyerly

   Research Article 29 October 2018 Pages: 721 - 728

   

5. The burden of cancer in Spain

   • X. Badía
   • M. Tort
   • E. Díaz-Rubio

   Research Article 09 November 2018 Pages: 729 - 734

6. Prognostic factors in neoadjuvant treatment followed by surgery in stage IIIA-N2 non-small cell lung cancer: a multi-institutional study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)

   • F. Couñago
   • S. Montemuiño
   • N. R. de Dios

   Research Article 14 November 2018 Pages: 735 - 744

   

7. The protective effects of melatonin on blood cell counts of rectal cancer patients following radio-chemotherapy: a randomized controlled trial

   • N. Kouhi Habibi
   • A. Shabestani Monfared
   • F. Niksirat

   Research Article 12 November 2018 Pages: 745 - 752

   

8. Laparoscopy adjuvant total colorectal resection for the treatment of familial adenomatous polyposis (FAP)

   • Z. Zhang
   • D. Wang
   • X. Zhang

   Research Article 21 November 2018 Pages: 753 - 759

   

9. Oncologic outcomes of nephron-sparing surgery in patients with T1 multifocal renal cell carcinoma

   • G. Li
   • D. Zhu
   • Y. Niu

   Research Article Open access 15 November 2018 Pages: 760 - 765

   

10. Diagnostic performance of ¹⁸F-choline PET-CT in prostate cancer

    • P. Samper Ots
    • A. Luis Cardo
    • J. Olivera Vegas

    Research Article 17 November 2018 Pages: 766 - 773

    

11. Health-related quality of life analysis in stage III melanoma patients treated with adjuvant dendritic cell therapy

    • M. Bloemendal
    • M. J. A. Rietveld
    • K. F. Bol

    Research Article Open access 21 November 2018 Pages: 774 - 780

    

12. Omitting the lower neck and sparing the glottic larynx in node-negative nasopharyngeal carcinoma was safe and feasible, and improved patient-reported voice outcomes

    • F. Xiao
    • S. Dou
    • G. Zhu

    Research Article 04 December 2018 Pages: 781 - 789

    

13. Metronomic oral vinorelbine for the treatment of advanced non-small cell lung cancer: a multicenter international retrospective analysis

    • A. Camerini
    • G. L. Banna
    • F. Barata

    Research Article 17 November 2018 Pages: 790 - 795

14. Active surveillance as a successful management strategy for patients with clinical stage I germ cell testicular cancer

    • R. Escudero-Ávila
    • J. D. Rodríguez-Castaño
    • I. Duran

    Research Article 23 November 2018 Pages: 796 - 804

    

15. Improvement of appropriate pharmacological prophylaxis in hospitalised cancer patients with a multiscreen e-alert system: a single-centre experience

    • R. Figueroa
    • A. Alfonso
    • R. Lecumberri

    Brief Research Article 16 November 2018 Pages: 805 - 809

16. Statin treatment and outcomes of metastatic pancreatic cancer: a pooled analysis of two phase III studies

    • O. Abdel-Rahman

    Brief Research Article 21 November 2018 Pages: 810 - 816

    

17. Correction to: SEOM Clinical Guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2016)

    • M. Lázaro
    • E. Gallardo
    • S. Vázquez

    Correction 26 February 2019 Pages: 817 - 817